1. Home
  2. VSEC vs MIRM Comparison

VSEC vs MIRM Comparison

Compare VSEC & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSEC
  • MIRM
  • Stock Information
  • Founded
  • VSEC 1959
  • MIRM 2018
  • Country
  • VSEC United States
  • MIRM United States
  • Employees
  • VSEC N/A
  • MIRM N/A
  • Industry
  • VSEC Military/Government/Technical
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSEC Consumer Discretionary
  • MIRM Health Care
  • Exchange
  • VSEC Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • VSEC 2.1B
  • MIRM 1.9B
  • IPO Year
  • VSEC N/A
  • MIRM 2019
  • Fundamental
  • Price
  • VSEC $112.89
  • MIRM $40.80
  • Analyst Decision
  • VSEC Strong Buy
  • MIRM Strong Buy
  • Analyst Count
  • VSEC 6
  • MIRM 11
  • Target Price
  • VSEC $118.00
  • MIRM $58.55
  • AVG Volume (30 Days)
  • VSEC 281.1K
  • MIRM 432.9K
  • Earning Date
  • VSEC 05-06-2025
  • MIRM 05-07-2025
  • Dividend Yield
  • VSEC 0.36%
  • MIRM N/A
  • EPS Growth
  • VSEC N/A
  • MIRM N/A
  • EPS
  • VSEC 0.85
  • MIRM N/A
  • Revenue
  • VSEC $1,080,132,000.00
  • MIRM $336,888,000.00
  • Revenue This Year
  • VSEC N/A
  • MIRM $29.51
  • Revenue Next Year
  • VSEC $12.37
  • MIRM $20.27
  • P/E Ratio
  • VSEC $131.54
  • MIRM N/A
  • Revenue Growth
  • VSEC 25.53
  • MIRM 80.76
  • 52 Week Low
  • VSEC $73.36
  • MIRM $23.83
  • 52 Week High
  • VSEC $128.72
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • VSEC 50.69
  • MIRM 45.27
  • Support Level
  • VSEC $107.50
  • MIRM $38.22
  • Resistance Level
  • VSEC $114.29
  • MIRM $39.87
  • Average True Range (ATR)
  • VSEC 6.49
  • MIRM 2.27
  • MACD
  • VSEC -0.13
  • MIRM 0.23
  • Stochastic Oscillator
  • VSEC 66.36
  • MIRM 61.83

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management and consulting services for land, sea and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. Majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business and general aviation operators.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: